ACT Genomics is a world-leading genomic test solution provider. Our mission is to make personalized medicine accessible to all. We offer precision medicine services globally. Combining tumor biology, cancer genomics, and bioinformatics experts to provide treatment guidelines for solid tumors, relapse, and drug resistance, as well as cancer monitoring, risk assessment, and immunotherapy evaluation. We are dedicated to turning every cancer patient's genetic information into actionable resolutions through cutting-edge next-generation sequencing (NGS) platforms, bioinformatics analysis, and comprehensive service offerings. Our NGS platform, coupled with sophisticated bioinformatics tools and curated proprietary databases, enables us to deliver reliable results for clinical and research purposes, and our data visualization technologies make the scientific results easily understandable for everyone. Our clinical services include cancer prevention, early detection, treatment selection, and disease monitoring. Our genomic assays offer comprehensive cancer genomic profiling and treatment options for patients with cancer and provide insights into biomarker discovery and patient stratification for clinical trials.
ACT Genomics is a world-leading genomic test solution provider. Our mission is to make personalized medicine accessible to all. We offer precision medicine services globally. Combining tumor biology, cancer genomics, and bioinformatics experts to provide treatment guidelines for solid tumors, relapse, and drug resistance, as well as cancer monitoring, risk assessment, and immunotherapy evaluation. We are dedicated to turning every cancer patient's genetic information into actionable resolutions through cutting-edge next-generation sequencing (NGS) platforms, bioinformatics analysis, and comprehensive service offerings. Our NGS platform, coupled with sophisticated bioinformatics tools and curated proprietary databases, enables us to deliver reliable results for clinical and research purposes, and our data visualization technologies make the scientific results easily understandable for everyone. Our clinical services include cancer prevention, early detection, treatment selection, and disease monitoring. Our genomic assays offer comprehensive cancer genomic profiling and treatment options for patients with cancer and provide insights into biomarker discovery and patient stratification for clinical trials.
Company Information
- Industry
- Company Type
- Privately Held
- Founded
- 2014
- Employee Range
- 51-200
- Revenue Range
- Not available
Location
- Address
- 3F ., No.345, Xinhu 2nd Rd., Neihu Dist Taipei
- City
- Region
- Postal Code
- 11494
- Country
- Taiwan